Publications

Export 30 results:
Author [ Title(Desc)] Type Year
Filters: Author is Jollant, F  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Kennedy SH, Lam RW, McIntyre RS, S Tourjman V, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, Macqueen GM et al..  2016.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.. Can J Psychiatry. 61(9):540-60.
Richard-Devantoy S, Ding Y, Lepage M, Turecki G, Jollant F.  2016.  Cognitive inhibition in depression and suicidal behavior: a neuroimaging study.. Psychol Med. 46(5):933-44.
Cyprien F, de Champfleur NMenjot, Deverdun J, Olié E, Le Bars E, Bonafé A, Mura T, Jollant F, Courtet P, Artero S.  2016.  Corpus callosum integrity is affected by mood disorders and also by the suicide attempt history: A diffusion tensor imaging study.. J Affect Disord. 206:115-124.
Gifuni AJ, Olié E, Ding Y, Cyprien F, Le Bars E, Bonafé A, Courtet P, Jollant F.  2017.  Corpus callosum volumes in bipolar disorders and suicidal vulnerability.. Psychiatry Res. 262:47-54.
Lopez JPablo, Pereira F, Richard-Devantoy S, Berlim M, Chachamovich E, Fiori LM, Niola P, Turecki G, Jollant F.  2017.  Co-Variation of Peripheral Levels of miR-1202 and Brain Activity and Connectivity During Antidepressant Treatment.. Neuropsychopharmacology.
Maussion G, Cruceanu C, Rosenfeld JA, Bell SC, Jollant F, Szatkiewicz J, Collins RL, Hanscom C, Kolobova I, de Champfleur NMenjot et al..  2017.  Cover Image, Volume 173A, Number 2, February 2017.. Am J Med Genet A. 173(2):i.

Pages